SciSight Ecosystem
WoS SCIE Q3Scopus Q2SCImago #6,431CAS 3区Review JournalHybrid

Expert Review of Anticancer Therapy

Abbreviation (ISO):EXPERT REV ANTICANC
Country: England•WoS SCIE Quartile: Q3•Scopus SJR: 0.84•SCImago Rank: #6,431•Identifier (ISSN):1473-7140(Print)/1744-8328(Online)•Articles / Year: 99•Estimated Publication Fee (APC): $3,236 USD
Clarivate IF (2026)Q3
3
↑ +0.2

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
59

59 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
99articles/year
2.11% Gold OA•34.91% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q3(IF: 3)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.50đ
WoS Q3(IF: 3)
🔵 Computed
20251.50đ
WoS Q3(IF: 2.8)
🔵 Computed
20241.50đ
WoS Q3(IF: 2.9)
🔵 Computed
20231.50đ
WoS Q3(IF: 3.3)
🔵 Computed
20221.50đ
WoS Q3(IF: 3.627)
🔵 Computed
20211.50đ
WoS Q3(IF: 4.512)
🔵 Computed
20201.50đ
WoS Q3(IF: 3.573)
🔵 Computed
20191.50đ
WoS Q3(IF: 2.571)
🔵 Computed
20181.50đ
WoS Q3(IF: 2.347)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care. Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points.

Topics Covered (Recognized by AI)
Medicine99.9%Internal medicine89.5%Biology89.2%Genetics84.7%Oncology69.4%Cancer69.3%Pathology60.1%Surgery50%Chemistry34%Cancer research32.4%Immunology30.5%Biochemistry30%Chemotherapy28.2%Radiology28.1%Bioinformatics21.9%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,431Scopus Q2SCImago Profile
Scopus Coverage:2001-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.84

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q2
Scopus H-Index (2025)
91

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
2.84

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,236 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations1,036
3-Year Documents365
Citable Documents335

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate36.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ2
Pharmacology (medical)Q2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Taylor and Francis Ltd.
Publication Language
English
Frequency
Bimonthly
Founding Year
2001
Editorial Address
EXPERT REVIEWS, UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRSCIE
172/333Q3
ONCOLOGY
JCISCIE
242/333Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—9437
20252.8187478
20242.9118625
20233.31151,116
20223.6271171,161
20214.5121041,515
20203.5731563,051
20192.571871,929
20182.3471284,762
2017—1204,925
2016—1363,062
2015—1453,311
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Expert Review of Anticancer Therapy

WoS Q3
1346201820192020202120222023202420252.80
Annual Impact Factor Metric
2025:2.8

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 8d02b446-42a8-4cdb-b02b-3662e795e73f
Database Updated: 2026-09-29